AKT1 and breast carcinoma: Mechanistic studies demonstrated that overexpression of a mutated form of PELP1 that lacks the nuclear localization signal was able to drive MAPK signaling and constitutive AKT activation in unstimulated breast cancer cells, resulting in increased phosphorylation of ERα at Serine 118 and Serine 167 [19].